Clayton, Dubilier & Rice, LLC

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 9, 2026), Clayton, Dubilier & Rice, LLC reported 2 stock positions worth $595.0 million. Its top holding was Resideo Technologies (REZI) at 88.4% of the portfolio, followed by Agilon Health (AGL, 11.6%). Compared with Q3 2025, it added to 1. The biggest buy was Resideo Technologies (REZI, shares +13%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001538642
Portfolio Value
$595.0M (Q4 2025)
SEC Filing
0001104659-26-011833 ↗ filed Feb 9, 2026

Holdings Value

0$200.0M$400.0M$600.0M$800.0M$1.0B Q1 2024: $618.7M Q1 2024 Q2 2024: $661.9M Q2 2024 Q3 2024: $401.6M Q3 2024 Q4 2024: $192.6M Q4 2024 Q1 2025: $435.8M Q1 2025 Q2 2025: $357.3M Q2 2025 Q3 2025: $676.7M Q3 2025 Q4 2025: $595.0M $595.0M Q4 2025 Q1 2026: $536.5M Q1 2026 Q2 2026: $895.0M Q2 2026

Holdings 2 stocks · $595.0M
REZI Resideo Technologies Inc. 88.40% 14,976,142 $526.0M Add +12.7%
AGL Agilon Health Inc. 11.60% 100,000,000 $69.0M No change

Portfolio Sells Q3 2025 → Q4 2025
None this quarter.

Portfolio Buys Q3 2025 → Q4 2025
REZI Resideo Technologies Inc. Add +12.7% 88.40% +3.62

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$895.0MREZI, AGL
Q1 2026 2$536.5MREZI, AGL
Q4 2025 2$595.0MREZI, AGL
Q3 2025 2$676.7MREZI, AGL
Q2 2025 2$357.3MAGL, REZI
Q1 2025 2$435.8MAGL, BECN
Q4 2024 3$192.6MAGL, BECN, FTDR
Q3 2024 4$401.6MAGL, GPK, BECN, FTDR
Q2 2024 4$661.9MAGL, GPK, BECN, FTDR
Q1 2024 4$618.7MAGL, GPK, BECN, FTDR